Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) OverviewLatest ebit for IQMDU: $4.4T, above the sector sector average of $-69M.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2022
Trailing 12 months ending Dec 31, 2022
Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) (IQMDU) currently reports a EBIT of $4.4T as of December 2022. That is above the sector sector average of $-69M. Use the charts on this page to explore Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s EBIT history and peer comparisons.
Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s EBIT of $4.4T is higher than the its sector sector average of $-69M. That is roughly 6326484.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) reported $4.4T in EBIT as of December 2022. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $4.4T, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-69M. From there, open related valuation or income-statement pages for Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War), and consider following IQMDU for alerts when major investors trade the stock.
